The efficacy of a new group of antidepressants (selective serotonin reuptake inhibitors-SSRIs), were compared to other tricyclic antidepressants (TCAs) for the treatment of depressive illness.

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.